Sweden and Denmark Halt Moderna Vaccinations on Those 30-and-Under Due to Potential Side Effects - Plus Finland

Sweden and Denmark Halt Moderna Vaccinations on Those 30-and-Under Due to Potential Side Effects
Date: October 7, 2021Author: Nwo Report




Source:  Jim Hoft
Sweden and Denmark announced on Tuesday they were halting Moderna COVID vaccinations for those under 30-years-old due to possible side effects.
This is very big news.
The two nations saw ample evidence to ban the vaccine for its youth.
Bloomberg.com reported:

Sweden and Denmark decided to halt vaccinations with Moderna Inc.’s Covid-19 shot for younger people because of potential side effects.
The Swedish health authority Wednesday cited new data on the increased risk of heart inflammation as a reason for the pause for those aged 30 and under. Denmark will stop giving the shot to those younger than 18.
Moderna shares fell as much as 5.3% in New York trading.
“We are monitoring the situation closely and are acting rapidly to ensure that Covid-19 vaccinations are constantly as safe as possible, while also providing protection,” said Anders Tegnell, Sweden’s chief epidemiologist.
The two countries recommended Pfizer Inc.’s and BioNTech SE’s rival vaccine as a replacement. Both vaccinations use messenger RNA technology to prompt an immune reaction.

According to the VAERS tracking website, in the United States, 3,933 Americans have died following the Moderna COVID vaccination. 10,848 have died due to the Pfizer vaccination.


https://nworeport.me/2021/10/07/sweden-and-denmark-halt-moderna-vaccinations-on-those-30-and-under-due-to-potential-side-effects/
Thanks to: https://nworeport.me

Finland Follows Sweden and Denmark in Halting Use of Moderna Vaccine for Younger Age Group
Date: October 7, 2021Author: Nwo Report




Source: Lorenz Duchamps
Finish health authorities have paused the use of Moderna’s COVID-19 vaccine on Oct. 7 for men under the age of 30, just one day after Sweden and Denmark announced a similar measure due to side effects.
Mika Salminen, head of the Finnish health institute, said the Nordic country would instead give the Pfizer vaccine to men born in 1991 and later. Health officials said the decision was taken due to reports of a rare cardiovascular side effect.
“A Nordic study involving Finland, Sweden, Norway, and Denmark found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk than others of developing myocarditis,” Salminen said.
Swedish health officials on Oct. 6 also halted the use of the Moderna COVID-19 vaccine for younger people and children after reports of possible side effects including myocarditis. Danish officials announced that it will halt the shot for those under the age of 18 due to similar concerns.
According to a statement from the Swedish health agency that was translated from Swedish to English, there is “an increased risk of side effects such as inflammation of the heart muscle or heart sac,” although the agency noted that the risk is “very small.”
“The connection is especially clear when it comes to Moderna’s vaccine Spikevax, especially after the second dose,” the health agency said.
Severe cases of myocarditis, an inflammation of the heart muscle, can lead to heart failure or even sudden death. Symptoms of the infection can include chest pain, rapid or abnormal heart rhythms, and shortness of breath.
A Moderna spokesperson had said after Sweden and Denmark’s Oct. 6 announcement that the company was made aware of the decisions by the country’s regulators.
“These are typically mild cases and individuals tend to recover within a short time following standard treatment and rest,” the spokesperson for the U.S.-based pharmaceutical company said, adding that unvaccinated people are still at a higher risk of getting myocarditis from COVID-19 than those who are vaccinated.
The Nordic countries based the decision on an unpublished research study that included data from Finland, Sweden, Norway, and Denmark. Officials said the research will be published within a couple of weeks and preliminary data had been sent to the European Medicines Agency (EMA) for further assessment.
In July, EMA, the European Union’s chief drug regulator, recommended authorizing Moderna’s COVID-19 vaccine for children ages 12 to 17. It came months after the Moderna vaccine was given approval for use in anyone aged 18 and older across the 27-nation bloc in January.
Both U.S. and European regulators have cautioned that the Moderna and Pfizer vaccines, which use mRNA technology, are linked to chest pain and heart inflammation in young people and children, although those agencies have frequently said those reactions are rare.

https://nworeport.me/2021/10/07/finland-follows-sweden-and-denmark-in-halting-use-of-moderna-vaccine-for-younger-age-group/